Technology and science as global public goods: Tackling priority diseases of poor countries;La science et la technologie en tant que biens publics mondiaux: S'attaquer aux maladies prioritaires des pays pauvres

Revue d'Economie du Developpement

Volumn 16, Issue 1-2, 2002, Pages 117-139

  Mills, Anne ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Dans le Cadre de Cette Recherche

Author keywords

[No Author keywords available]

Indexed keywords

EID: 31344481187     PISSN: 12454060     EISSN: None     Source Type: Journal    
DOI: 10.3917/edd.161.0117     Document Type: Article

References (31)

1. th.
2. ATTARAN, A., M. KREMER, J. SACHS & S. SIEVERS (2000), A Tax Credit for Sales of HIV, Tuberculosis, and Malaria Vaccines, Center for International Development, Harvard University.
3. BALA K. and K. SAGOO (2000), Patents and prices, HAI news, April-May, 1-9.
4. BUSE, K. and G. WALT (2000), Mondial public-private partnerships: Part II, WHO Bull, 78(5), 569-714.
5. st Century, Oxford University Press, pp. 284-304.
6. CMH Working Group 5 (2001), Improving health outcomes of the poor, Draft report, London School of Hygiene and Tropical Medicine.
7. GLENNERSTER, R. & M. KREMER (2000), A Better Way to Spur Medical Research and Development, Regulation, 23(2), 34-39.
8. Mondial Forum for Health Research (2000), Session on Resource Flows into Health Research, Annual Forum on Health Research, Forum 4, Bangkok, 10-13 October 2000.
9. Mondial Forum for Health Research (2000), The 10/90 Report on Health Research 2000, Mondial Forum for Health Research.
10. JAMISON, D., J. FRENK and F. KNAUL (1998), International collective action in health: objectives, functions and rationale, Lancet, 351(9101), 514-7.
11. JUMA, C. (1999), Intellectual Property Rights and Globalization: Implications for Developing Countries, Science, Technology and Innovation Discussion paper, No. 4, Center for International Development, Harvard University, Cambridge, MA, USA.
12. KANBUR, R., T. SANDLER & K. M. MORRISON (1999), The Future of Development Assistance: Common Pools and International Public Goods, Overseas Development Council, Policy Essay, No. 26.
13. KAUL, I. (2001), Mondial Public Goods and the Poor, Development, 44(1), 77-84.
14. st Century, Oxford University Press, pp2-9.
15. KETTLER, H. E. (1999), Updating the cost of a new chemical entity, London, Office of Health Economics
16. KREMER, M. (2000), Stimulating R & D on Vaccines for AIDS, Tuberculosis, and Malaria: The Role of Tax Credits for Sales of Vaccines to Non-Profit Organisations, Harvard University.
17. LANJOUW J. O. and I. COCKBURN (2000), Do Patents Matter?: Empirical Evidence after GATT, NBER Working Paper, No. W 7495.
18. LISTER, G. (2000), Mondial Health and Development: the Impact of Globalisation on the Health of Poor People, Contributing to DFID White Paper on Eliminating World Poverty: Making Globalisation Work for the Poor, 2000.
19. MEDLIN, C. & H. E. KETTLER (2000), (Confidential), Intellectual Property Rights and Mondial Health: Challenges for Access and R & D, A Report of the Joint Meeting of the Wellcome Trust and the Commission on Macroeconomics and Health (CMH) held at the Wellcome Trust Genome Campus, Hinxton Hall Conference Centre, Hinxton, Cambridgeshire, UK on December 7-9, 2000.
20. MICHAUD, C. & C. J. L. MURRAY (1996), Resources for health research and development in 1992: a mondial overview, in World Health Organisation, Investing in Health Research and Development, Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options, 213-234.
21. PIU (2001), Tackling the Diseases of Poverty - Meeting the Okinawa/Millennium Targets for HIV/AIDS, Tuberculosis, and Malaria, Performance and Innovation Unit, Cabinet Office, London.
22. th March), 1979-1981.
23. SHRETTA R., G. WALT, R. BRUGHA, R. SNOW (2001), A political analysis of corporate drug donations: the example of Malarone in Kenya, Health Policy and Planning, 16(2), 161-170.
24. st Century, Oxford University Press, pp. 308-325.
25. WADDINGTON C. (2001), Don't be distracted from good routine immunisation, GAVI Immunisation Focus, March.
26. WALT G. (2000), Mondial co-operation in public health, in M. H. MERSON, R. E. BLACK amd A. J. MILLS, International Public Health. Diseases, Programs, Systems and Policies, Aspen Publishers, Gaithersburg.
27. WATAL J. (2001), Access to Essential Medicines in Developing Countries: Does the WTO TRIPS Agreement Hinder It?, Science, Technology and Innovation Discussion Paper, No. 8. Center for International Development, Harvard University, Cambridge, Mass.
28. WEBBER, D. & M. KREMER, Stimulating industrial R & D for neglected infectious diseases: economic perspectives. (Forthcoming in Bulletin of the World Health Organisation)
29. WHO (1996), Investing in health research and development, Ad Hoc Committee on Health Research Priorities, Geneva, WHO.
30. WORLD BANK (1999), World Development Report 1998/99, Oxford University Press.
31. WORLD BANK (2001), World Development Report 2000/01, Oxford University Press.